Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic

McFadden, Lisa M.

doi:10.1016/j.dadr.2023.100155

Drug and Alcohol Dependence Reports

2023

DOI: 10.1016/j.dadr.2023.100155

|View full text |Cite

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic

Lisa M. McFadden

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Changes in Substance Use Diagnoses in the Great Plains during the COVID-19 Pandemic

Nahian,

McFadden

2024

Healthcare

View full text Add to dashboard Cite

As drug overdose mortality rises in the United States, healthcare visits present critical opportunities to mitigate this trend. This study examines changes in healthcare visits for substance use disorders (SUDs) and remission prior to and during the COVID-19 pandemic in the Great Plains, with a focus on identifying the characteristics of those served. Data were analyzed from 109,671 patient visits (mode = one visit per patient), encompassing diverse demographics, including sex, age, race, ethnicity, and geographic location. Visits analyzed included those for Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD), or Stimulant Use Disorder (StUD) and those in remission of these disorders between March 2019 and March 2021. Patient demographic information and geographic factors, like rurality and Medicaid expansion status, were considered, and logistic regression was utilized. Visits were primarily by White (70.83%) and Native American (21.39%) patients, non-Hispanic (91.70%) patients, and males (54.16%). Various demographic, geographic, and temporal trends were observed. Findings indicated that males were more likely to receive an AUD diagnosis, while females were more likely to receive an OUD or StUD diagnosis. Metropolitan-residing patients were more likely to receive an AUD diagnosis, while non-metropolitan patients were more likely to receive an OUD diagnosis. Remission odds increased for StUD during the pandemic but decreased for AUD and OUD. These findings illuminate the demographic and geographic patterns of SUD-related healthcare visits, suggesting critical touchpoints for intervention. The results emphasize the urgent need for targeted healthcare strategies, especially in rural and underserved areas, to address persistent health disparities.

show abstract

Changes in Substance Use Diagnoses in the Great Plains during the COVID-19 Pandemic

Nahian,

McFadden

2024

Healthcare

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic

Cited by 1 publication

References 32 publications

Changes in Substance Use Diagnoses in the Great Plains during the COVID-19 Pandemic

Changes in Substance Use Diagnoses in the Great Plains during the COVID-19 Pandemic

Contact Info

Product

Resources

About